Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Oct 6, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Notice to Extend PA-20-074 "Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support (R18)"
Agency for Healthcare Research and Quality
- Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Awards
National Institutes of Health
General Notices
- Change to NIDCD Administrative Reduction Guidance for Modular R01 Awards
National Institute on Deafness and Other Communication Disorders
- NIDCR Guidance on Applications for Investigator-Initiated Clinical Trials
National Institute of Dental and Craniofacial Research
- Notice to Rescind NOT-EB-21-018 Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)
National Institute of Biomedical Imaging and Bioengineering
- Autism Centers of Excellence (ACE) Funding Opportunity Announcements: Frequently Asked Questions
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- NIH Request for Information (RFI): Search Capabilities across the Biomedical Landscape for NIH-wide Data Discovery
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Correction to Salary information in PAR-21-295, NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Correction to PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
National Cancer Institute
- Notice of Early Termination of RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)"
National Cancer Institute
- Notice of NIDA's Participation in PA-20-144, "Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of NIDA's Participation in PA-20-145, "Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Early Expiration of PAR-21-022, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Early Expiration of PAR-21-023, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of clarification in RFA-DA-22-022, " Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Change to Award Information and Application and Submission Instructions for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Research Strategy Section Page Limits for RFA-DK-21-502, Limited Competition for the Data Coordinating Center (DCC) for the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U24 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Extension of Application Due Date and Funding Opportunity Announcement (FOA) Identified under Announcement Type for RFA-DK-20-028, Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Key Dates of RFA-MH-21-175, "BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)"
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- Notice of Change to NOT-NS-20-038 "Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)"
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Opportunities
- Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Cancer Institute
- NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
National Cancer Institute
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
National Institute of Mental Health
- Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
Only the current awardees of the Data Coordinating Center in the Caenorhabditis Intervention Testing Program, funded under RFA-AG-17-007, may apply to this Limited Competition FOA.
National Institute on Aging
- Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed)
Only the current awardees of the Caenorhabditis Intervention Testing Program, funded under RFA-AG-17-001, may apply to this Limited Competition FOA.
National Institute on Aging
- Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
Food and Drug Administration
- Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
National Institute of Mental Health
- INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
Office of the Director, NIH
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.